David Zhi Hao Li, DO
Sports Medicine · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Li’s office at (888) 926-9385 to ask if they take your plan before you enroll.
Medicaid work
$0 in 2024
Medicaid paid $0 for 1,968 billed services this clinician did in 2024, up to 77 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Medication list documented in medical record (COA) | 52 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 52 | $0 |
| BODY MASS INDEX DOCD | 352 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 209 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 56 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 45 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 325 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 27 | $0 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 13 | $0 |
| Short return visit (20+ min) | 564 | $0 |
| Return visit (30+ min) | 234 | $0 |
| Long return visit (40+ min) | 39 | $0 |
| 2024 | 1,968 | 12 | 77 | $0 |
| 2023 | 1,782 | 12 | 41 | $0 |
| 2022 | 273 | 8 | 29 | $0 |
See the largest Medicaid services in earlier years
2023
| TOBACCO USE ASSESSED | 20 | $0 |
| Pain severity quantified; pain present (COA) (ONC) | 58 | $0 |
| Advance care plan or similar legal document present in the medical record (COA) | 77 | $0 |
| Medication list documented in medical record (COA) | 59 | $0 |
| BODY MASS INDEX DOCD | 106 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 170 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 57 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 109 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 424 | $0 |
| Short return visit (20+ min) | 300 | $0 |
| Return visit (30+ min) | 353 | $0 |
| Long return visit (40+ min) | 49 | $0 |
2022
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose | 29 | $0 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose | 21 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 15 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 71 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 29 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use | 21 | $0 |
| Short return visit (20+ min) | 47 | $0 |
| Return visit (30+ min) | 40 | $0 |
Drugs they prescribed that Part D paid
$379,722
Pharmacies billed $379,722 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,032 generic and fewer than 11 brand-name prescriptions · $379,722 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 13 | $101,095 | $7,777 |
| Jardiance | 71 | $48,013 | $676 |
| Rybelsus | 29 | $29,564 | $1,019 |
| Arexvy | 60 | $17,899 | $298 |
| Xarelto | 27 | $16,847 | $624 |
See all 56 drugs
| Enbrel Sureclick | 13 | $101,095 | $7,777 |
| Jardiance | 71 | $48,013 | $676 |
| Rybelsus | 29 | $29,564 | $1,019 |
| Arexvy | 60 | $17,899 | $298 |
| Xarelto | 27 | $16,847 | $624 |
| Eliquis | 24 | $15,306 | $638 |
| Abrysvo | 47 | $14,757 | $314 |
| Januvia | 20 | $12,258 | $613 |
| Spiriva Respimat | 13 | $7,786 | $599 |
| Farxiga | 11 | $6,894 | $627 |
| Shingrix | 29 | $6,165 | $213 |
| Fluticasone Propionate Hfa | 13 | $4,811 | $370 |
| Atorvastatin | 318 | $4,102 | $13 |
| Colchicine | 13 | $3,317 | $255 |
| Lumigan | 11 | $2,953 | $268 |
| Alogliptin | 12 | $2,562 | $214 |
| Losartan | 188 | $2,392 | $13 |
| Finasteride | 102 | $1,710 | $17 |
| Tamsulosin | 102 | $1,624 | $16 |
| Fluticasone Propionate | 57 | $1,610 | $28 |
| Boostrix Tdap | 27 | $1,487 | $55 |
| Levocetirizine Dihydrochloride | 67 | $1,367 | $20 |
| Amlodipine Besylate | 165 | $1,321 | $8 |
| Febuxostat | 22 | $1,314 | $60 |
| Metoprolol | 76 | $1,298 | $17 |
| Esomeprazole Magnesium | 45 | $1,254 | $28 |
| Omeprazole | 94 | $1,190 | $13 |
| Gabapentin | 63 | $1,113 | $18 |
| Metformin | 91 | $993 | $11 |
| Rosuvastatin | 36 | $697 | $19 |
| Albuterol Sulfate Hfa | 13 | $648 | $50 |
| Alendronate | 49 | $498 | $10 |
| Allopurinol | 30 | $480 | $16 |
| Valsartan | 15 | $451 | $30 |
| Triamcinolone Acetonide | 32 | $446 | $14 |
| Levothyroxine | 27 | $417 | $15 |
| Furosemide | 38 | $401 | $11 |
| Azelastine | 20 | $376 | $19 |
| Memantine | 13 | $358 | $28 |
| Escitalopram | 27 | $348 | $13 |
| Nifedipine Er | 12 | $295 | $25 |
| Lisinopril | 30 | $289 | $10 |
| Pioglitazone | 13 | $264 | $20 |
| Metoprolol | 22 | $250 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $250 | $21 |
| Glipizide | 14 | $220 | $16 |
| Potassium Chloride | 12 | $218 | $18 |
| Sertraline | 16 | $207 | $13 |
| Latanoprost | 16 | $194 | $12 |
| Mirtazapine | 12 | $188 | $16 |
| Pravastatin | 12 | $180 | $15 |
| Montelukast | 11 | $164 | $15 |
| Timolol Maleate | 11 | $163 | $15 |
| Simvastatin | 13 | $147 | $11 |
| Methimazole | 12 | $138 | $11 |
| Hydrochlorothiazide | 14 | $109 | $8 |
Year by year
| 2024 | 2,613 | 135 | None | None | $379,722 |
| 2023 | 2,318 | 97 | 1% (14) | 18% | $234,691 |
| 2022 | 222 | 44 | None | None | $15,589 |
| 2021 | 129 | 63 | 0% (0) | 0% | $2,444 |
| 2020 | 209 | 96 | None | None | $6,686 |
| 2019 | 187 | 99 | None | None | $7,941 |
| 2018 | 215 | 113 | 5% (11) | None | $10,588 |
| 2017 | 239 | 142 | None | None | $10,119 |
| 2016 | 198 | 110 | None | None | $5,943 |
| 2015 | 325 | 54 | None | None | $12,695 |
| 2014 | 390 | 70 | None | 12% | $14,701 |
| 2013 | 290 | 66 | 6% (18) | None | $10,413 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 58 drugs
| Jardiance | 33 | $21,134 | $640 |
| Xarelto | 29 | $16,685 | $575 |
| Ozempic | 13 | $13,755 | $1,058 |
| Rybelsus | 13 | $12,257 | $943 |
| Eliquis | 19 | $11,920 | $627 |
| Januvia | 16 | $9,579 | $599 |
| Spiriva Respimat | 11 | $5,946 | $541 |
| Shingrix | 21 | $4,147 | $197 |
| Flovent Hfa | 11 | $4,002 | $364 |
| Atorvastatin | 238 | $3,338 | $14 |
| Colchicine | 15 | $2,832 | $189 |
| Havrix | 31 | $2,762 | $89 |
| Alogliptin | 12 | $2,515 | $210 |
| Febuxostat | 31 | $2,047 | $66 |
| Losartan | 126 | $1,830 | $15 |
| Tamsulosin | 107 | $1,801 | $17 |
| Fluticasone Propionate | 53 | $1,283 | $24 |
| Omeprazole | 94 | $1,275 | $14 |
| Diclofenac | 28 | $1,243 | $44 |
| Gabapentin | 52 | $1,208 | $23 |
| Metformin | 100 | $1,182 | $12 |
| Finasteride | 66 | $1,141 | $17 |
| Boostrix Tdap | 19 | $1,020 | $54 |
| Metoprolol | 53 | $1,008 | $19 |
| Amlodipine Besylate | 123 | $970 | $8 |
| Albuterol Sulfate Hfa | 17 | $956 | $56 |
| Levocetirizine Dihydrochloride | 44 | $905 | $21 |
| Esomeprazole Magnesium | 29 | $860 | $30 |
| Prednisolone Acetate | 13 | $767 | $59 |
| Memantine Hcl Er | 12 | $702 | $59 |
| Synthroid | 13 | $697 | $54 |
| Carbidopa-Levodopa | 12 | $670 | $56 |
| Allopurinol | 38 | $670 | $18 |
| Oxycodone-Acetaminophen | 13 | $552 | $42 |
| Furosemide | 44 | $508 | $12 |
| Pioglitazone | 21 | $504 | $24 |
| Triamcinolone Acetonide | 33 | $497 | $15 |
| Potassium Chloride | 26 | $482 | $19 |
| Rosuvastatin | 19 | $392 | $21 |
| Pantoprazole | 19 | $352 | $19 |
| Valsartan | 12 | $351 | $29 |
| Losartan-Hydrochlorothiazide | 16 | $345 | $22 |
| Alendronate | 32 | $338 | $11 |
| Oxybutynin Chloride Er | 13 | $336 | $26 |
| Escitalopram | 24 | $321 | $13 |
| Metformin Hcl Er | 22 | $317 | $14 |
| Mirtazapine | 17 | $315 | $19 |
| Levothyroxine | 16 | $310 | $19 |
| Lisinopril | 33 | $301 | $9 |
| Citalopram Hbr | 21 | $287 | $14 |
| Ibuprofen | 13 | $245 | $19 |
| Meloxicam | 22 | $231 | $11 |
| Glipizide | 11 | $219 | $20 |
| Pravastatin | 13 | $202 | $16 |
| Metoprolol | 14 | $154 | $11 |
| Simvastatin | 11 | $148 | $13 |
| Prednisone | 14 | $120 | $9 |
| Paxlovid (Eua) | 15 | $94 | $6 |
2022: 3 drugs
| Atorvastatin | 16 | $243 | $15 |
| Omeprazole | 13 | $165 | $13 |
| Amlodipine Besylate | 11 | $87 | $8 |
2021: 3 drugs
| Diclofenac | 58 | $1,510 | $26 |
| Gabapentin | 28 | $382 | $14 |
| Meloxicam | 14 | $105 | $8 |
2020: 5 drugs
| Diclofenac | 74 | $2,699 | $36 |
| Gabapentin | 30 | $388 | $13 |
| Ibuprofen | 21 | $335 | $16 |
| Meloxicam | 30 | $210 | $7 |
| Prednisone | 25 | $167 | $7 |
2019: 5 drugs
| Diclofenac | 94 | $5,511 | $59 |
| Lidocaine | 16 | $940 | $59 |
| Gabapentin | 16 | $264 | $17 |
| Ibuprofen | 17 | $260 | $15 |
| Meloxicam | 18 | $127 | $7 |
2018: 3 drugs
| Diclofenac | 126 | $7,009 | $56 |
| Ibuprofen | 26 | $564 | $22 |
| Naproxen | 14 | $197 | $14 |
2017: 4 drugs
| Diclofenac | 154 | $8,674 | $56 |
| Ibuprofen | 31 | $705 | $23 |
| Naproxen | 23 | $307 | $13 |
| Meloxicam | 12 | $96 | $8 |
2016: 5 drugs
| Diclofenac | 38 | $2,122 | $56 |
| Ibuprofen | 14 | $227 | $16 |
| Naproxen | 16 | $198 | $12 |
| Lisinopril | 12 | $134 | $11 |
| Simvastatin | 12 | $62 | $5 |
2015: 7 drugs
| Nystatin | 11 | $583 | $53 |
| Atorvastatin | 36 | $567 | $16 |
| Omeprazole | 15 | $245 | $16 |
| Simvastatin | 20 | $190 | $9 |
| Lisinopril | 24 | $135 | $6 |
| Metformin | 19 | $80 | $4 |
| Metoprolol | 11 | $39 | $4 |
2014: 9 drugs
| Atorvastatin | 31 | $585 | $19 |
| Omeprazole | 22 | $235 | $11 |
| Lisinopril | 29 | $147 | $5 |
| Metoprolol | 30 | $144 | $5 |
| Levothyroxine | 14 | $137 | $10 |
| Losartan | 16 | $119 | $7 |
| Amlodipine Besylate | 19 | $82 | $4 |
| Hydrochlorothiazide | 11 | $51 | $5 |
| Metformin | 11 | $50 | $5 |
2013: 7 drugs
| Metoprolol | 12 | $429 | $36 |
| Lisinopril | 19 | $88 | $5 |
| Metoprolol | 15 | $85 | $6 |
| Hydrochlorothiazide | 17 | $85 | $5 |
| Amlodipine Besylate | 24 | $78 | $3 |
| Losartan | 17 | $74 | $4 |
| Levothyroxine | 11 | $73 | $7 |
Money from drug and device companies
$25 in 2025
A payment is not proof that care is biased.
| Dexcom | Dexcom G6 Transmitter | $25 | 1 payment
|
See the published payment
| Dexcom | Meals · 2025-05-07 | Dexcom G6 Transmitter | $25 |
Professional record
- NPI
- 1861750507
- Licence
- CA 20A14459, NY 271358
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QS0010X (207QS0010X)
- Mailing address
- 350 Potrero Ave, Sunnyvale, CA, 94085
- NPI first listed
- 2012-05-01
- NPI last updated
- 2025-02-11
- NPI record certified
- 2025-02-11
This is when the NPI record was last certified, not a medical board exam.